260 related articles for article (PubMed ID: 32586174)
41. Agonist depot versus OCP programming of frozen embryo transfer: a retrospective analysis of freeze-all cycles.
Ozgur K; Berkkanoglu M; Bulut H; Humaidan P; Coetzee K
J Assist Reprod Genet; 2016 Feb; 33(2):207-14. PubMed ID: 26701802
[TBL] [Abstract][Full Text] [Related]
42. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
[TBL] [Abstract][Full Text] [Related]
43. Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization.
Mounce G; McVeigh E; Turner K; Child TJ
Fertil Steril; 2015 Oct; 104(4):915-920.e1. PubMed ID: 26255087
[TBL] [Abstract][Full Text] [Related]
44. The effect of accompanying dominant follicle development/ovulation on the outcomes of frozen-thawed blastocyst transfer in HRT cycle.
Yang X; Dong X; Huang K; Wang L; Xiong T; Ji L; Zhang H
Int J Clin Exp Pathol; 2013; 6(4):718-23. PubMed ID: 23573319
[TBL] [Abstract][Full Text] [Related]
45. Effect of artificial cycle with or without GnRH-a pretreatment on pregnancy and neonatal outcomes in women with PCOS after frozen embryo transfer: a propensity score matching study.
Wang Y; Hu WH; Wan Q; Li T; Qian Y; Chen MX; Tang XJ; Feng Q; Meng XQ; Adu-Gyamfi EA; Ding YB; Geng LH; Lv XY; Zhong ZH
Reprod Biol Endocrinol; 2022 Mar; 20(1):56. PubMed ID: 35337348
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the clinical outcome of frozen-thawed embryo transfer with and without pretreatment with a gonadotropin-releasing hormone agonist.
Kang J; Park J; Chung D; Lee SH; Park EY; Han KH; Choi SJ; Chung IB; Han HD; Jung YS
Obstet Gynecol Sci; 2018 Jul; 61(4):489-496. PubMed ID: 30018903
[TBL] [Abstract][Full Text] [Related]
47. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
48. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
[TBL] [Abstract][Full Text] [Related]
49. Single-dose administration of a short-acting gonadotropin-releasing hormone agonist does not affect cycle outcome in frozen-thawed embryo transfer cycles.
Wang H; Tang X; Bukulmez O; Deng C; Yu Q; Zhou Y; Sun Z; Zhen J; Wang X; Liu M
J Int Med Res; 2021 May; 49(5):3000605211012247. PubMed ID: 33947255
[TBL] [Abstract][Full Text] [Related]
50. The addition of single dose GnRH agonist to luteal phase support in artificial cycle frozen embryo transfer: a randomized clinical trial.
Ye H; Luo X; Pei L; Li F; Li C; Chen Y; Zhang X; Huang G
Gynecol Endocrinol; 2019 Jul; 35(7):618-622. PubMed ID: 30700175
[TBL] [Abstract][Full Text] [Related]
51. Is the long-acting gonadotropin-releasing hormone agonist long protocol better for patients with endometriosis undergoing IVF?
Wang X; Li W; Chen X; Zhang W; Chu M; Yin S; Chu Y; Liu X
Int J Gynaecol Obstet; 2023 Jul; 162(1):325-332. PubMed ID: 36688363
[TBL] [Abstract][Full Text] [Related]
52. Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles.
Tatsumi T; Jwa SC; Kuwahara A; Irahara M; Kubota T; Saito H
Hum Reprod; 2017 Jun; 32(6):1244-1248. PubMed ID: 28398491
[TBL] [Abstract][Full Text] [Related]
53. Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis.
Li M; Xu L; Zhao H; Du Y; Yan L
Sci Rep; 2021 Sep; 11(1):19326. PubMed ID: 34588576
[TBL] [Abstract][Full Text] [Related]
54. Comparison between oral dydrogesterone versus micronized vaginal progesterone gel in clinical outcome within the first HRT-FET cycle: a retrospective analysis.
Ye TM; Luo LD; Huang YF; Ding S
Arch Gynecol Obstet; 2024 May; 309(5):2167-2173. PubMed ID: 38503849
[TBL] [Abstract][Full Text] [Related]
55. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
56. Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study.
Zhao F; Lan Y; Chen T; Xin Z; Liang Y; Li Y; Wang S; Zhang J; Yang X
J Ovarian Res; 2020 Feb; 13(1):23. PubMed ID: 32113477
[TBL] [Abstract][Full Text] [Related]
57. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
Ren J; Sha A; Han D; Li P; Geng J; Ma C
Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
[TBL] [Abstract][Full Text] [Related]
58. Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome.
Zhang J; Liu H; Wang Y; Mao X; Chen Q; Fan Y; Xiao Y; Kuang Y
Fertil Steril; 2019 Aug; 112(2):371-377. PubMed ID: 31126712
[TBL] [Abstract][Full Text] [Related]
59. Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
Xu Z; Meng L; Pan C; Chen X; Huang X; Yang H
Gynecol Endocrinol; 2019 Feb; 35(2):124-127. PubMed ID: 30303700
[TBL] [Abstract][Full Text] [Related]
60. GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression.
Surrey ES; Katz-Jaffe M; Kondapalli LV; Gustofson RL; Schoolcraft WB
Reprod Biomed Online; 2017 Aug; 35(2):145-151. PubMed ID: 28601378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
